Emerging Players in the South Korea Albumin Market | Competitive Landscape 2026

South Korea Albumin Market Overview

According to 6Wresearch, South Korea albumin market is experiencing tremendous growth, on account of rising prevalence of chronic conditions and increasing need for effective fluid resuscitation solutions. Albumin is an essential plasma-derived protein, that is used in the treatment of liver cirrhosis, severe burns and hypovolemia due to trauma.

Increasing usage of advanced plasma fractionation technologies, and rising demand for high concentration albumin solutions for clinical applications are the key factors driving the growth of the plasma fractionation market. The government has also launched several schemes to provide improved health care facilities, and to achieve universal health coverage for lifesaving plasma products.

Competitive Landscape

The South Korea albumin industry is competitive, with several global and domestic players, particularly in the biopharmaceutical and plasma-derived drugs segments. The dominant companies are continuously investing in R&D, which helps them to retain their market positions. This is further permitting the development of purified and pathogen-safe albumin formulations to cater to the growing demand for effective albumin therapies.

Below is a list of leading players operating in the South Korea Albumin Market:

1. GC Biopharma

GC Biopharma is a domestic leader in plasma-derived therapies, providing high-quality human albumin solutions for fluid volume management.

2. SK Plasma

SK Plasma leads with a vast portfolio of plasma-derived products, specializing in albumin treatments for patients with complex protein deficiencies and expanding infrastructure globally.

3. CSL Behring South Korea

CSL Behring is a global biotherapeutics leader, offering specialized albumin products used extensively in the treatment of cirrhosis and chronic liver diseases.

4. Grifols South Korea

Grifols is a pioneer in plasma fractionation, providing highly purified human albumin solutions, contributing significantly to the management of hypovolemia and shock.

5. Octapharma South Korea

Octapharma remains a dominant force, providing critical care products and albumin solutions that cater to a large patient base requiring renal and surgical fluid support.

6. Kedrion Biopharma South Korea

Kedrion provides a complete array of plasma-derived medicinal products, including human albumin used for blood volume restoration.

7. Biotest South Korea

Biotest is a key player in the development and distribution of plasma proteins, offering targeted albumin therapies for clinical immunology and intensive care medicine.

8. Takeda South Korea

Takeda offers a wide portfolio of hospital-grade medicines, including essential albumin solutions used in specialized clinical settings and intensive care units.

9. Boryung Corp.

Boryung is one of Korea's most trusted pharmaceutical brands, providing accessible hospital-grade solutions and supporting the supply of essential blood-related treatments.

10. Hanmi Pharmaceutical

Hanmi maintains a strong presence through its robust distribution network, providing cost-effective and essential plasma-derived solutions to the healthcare system.